SWOG clinical trial number
SWOG-9307

Extended Administration of Oral Etoposide And Oral Cyclophosphamide for the Treatment of Poor Prognosis Extensive Disease Small Cell Lung Cancer, Phase II Pilot

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Extended Administration of Oral Etoposide And Oral Cyclophosphamide for the Treatment of Poor Prognosis Extensive Disease Small Cell Lung Cancer, Phase II Pilot
Activated
07/01/1993
Closed
06/01/1996

Research committees

Lung Cancer

Publication Information Expand/Collapse

1999

Treatment of poor prognosis extensive disease small cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - A Southwest Oncology Group clinical and pharmacokinetic study.

SM Grunberg;JJ Crowley;KR Hande;DJ Giroux;NC Munshi;DHM Lau;LE Schroder;MH Zangmeister;SP Balcerzak;HE Hynes;DR Gandara Cancer Chemotherapy and Pharmacology 44:461-468

1997

Oral etoposide (VP) and oral cyclophosphamide (CP) for poor prognosis extensive disease (ED) small cell lung cancer (SCLC). A Southwest Oncology Group clinical and pharmacokinetic study.

SM Grunberg;D Rector;K Hande;R Livingston Lung Cancer 18(Suppl.1)(#85):24-25

1994

Extended oral etopside (E) and oral cyclophosphamide (C) for lung cancer

SM Grunberg;J Crowley;R Livingston Lung Cancer 11(Suppl.1):121(#464)

Other Clinical Trials

SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
1%
Open
Phase
SWOG Clinical Trial Number
A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open